JAY MISHRA

Dr. JAY MISHRA

University of Wisconsin- Madison, Department of Comparative Biosciences, School of Vet Med, Madison, USA
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2011 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
KSKunal Sharan
Kunal Sharan
JMJAY MISHRA
JAY MISHRA
GSGaurav Swarnkar
Gaurav Swarnkar
Jawed A SiddiquiJawed A Siddiqui
Jawed A Siddiqui
KKKainat Khan
Kainat Khan
NCNaibedya Chattopadhyay
Naibedya Chattopadhyay
We recently reported that extracts made from the stem bark of Ulmus wallichiana promoted peak bone mass achievement in growing rats and preserved trabecular bone mass and cortical bone strength in ovariectomized (OVX) rats. Further, 6-C-β-D-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanol (GTDF), a novel flavonol-C-glucoside isolated from the extracts, had a nonestrogenic bone-sparing effect on OVX rats. Here we studied the effects of GTDF on osteoblast function and its mode of action and in vivo osteogenic effect. GTDF stimulated osteoblast proliferation, survival, and differentiation but had no effect on osteoclastic or adipocytic differentiation. In cultured osteoblasts, GTDF transactivated the aryl hydrocarbon receptor (AhR). Activation of AhR mediated the stimulatory effect of GTDF on osteoblast proliferation and differentiation. Furthermore, GTDF stimulated cAMP production, which mediated osteogenic gene expression. GTDF treatments given to 1- to 2-day-old rats or adult rats increased the mRNA levels of AhR target genes in calvaria or bone marrow stromal cells. In growing female rats, GTDF promoted parameters of peak bone accrual in the appendicular skeleton, including increased longitudinal growth, bone mineral density, bone-formation rate (BFR), cortical deposition, and bone strength. GTDF promoted the process of providing newly generated bone to fill drill holes in the femurs of both estrogen-sufficient and -deficient rats. In osteopenic OVX rats, GTDF increased BFR and significantly restored trabecular bone compared with the ovaries-intact group. Together our data suggest that GTDF stimulates osteoblast growth and differentiation via the AhR and promotes modeling-directed bone accrual, accelerates bone healing after injury, and exerts anabolic effects on osteopenic rats likely by a direct stimulatory effect on osteoprogenitors. Based on these preclinical data, clinical evaluation of GTDF as a potential bone anabolic agent is warranted. © 2011 American Society for Bone and Mineral Research

1 November 2018 in Reproduction
Verified
Journal Article
Open access
PDF file
SKSathish Kumar
Sathish Kumar
GGGeoffrey H Gordon
Geoffrey H Gordon
DADavid H Abbott
David H Abbott
JMJAY MISHRA
JAY MISHRA
Adequate maternal vascular adaptations and blood supply to the uterus and placenta are crucial for optimal oxygen and nutrient transport to growing fetuses of eutherian mammals, including humans. Multiple factors contribute to hemodynamics and structuring of placental vasculature essential for term pregnancy with minimal complications. In women, failure to achieve or sustain favorable pregnancy progression is, not surprisingly, associated with high incidence of antenatal complications, including preeclampsia, a hypertensive disorder of pregnancy. While the pathogenesis of preeclampsia in women remains unknown, a role for androgens is emerging. The relationship between androgens and maternal cardiovascular and placental function deserves particular consideration because testosterone levels in the circulation of preeclamptic women are elevated approximately two- to three-fold and are positively correlated with vascular dysfunction. Preeclampsia is also associated with elevated placental androgen receptor (AR) gene expression. Studies in animal models mimicking the pattern and level of increase of adult female testosterone levels to those found in preeclamptic pregnancies, replicate key features of preeclampsia, including gestational hypertension, endothelial dysfunction, exaggerated vasoconstriction to angiotensin II, reduced spiral artery remodeling, placental hypoxia, decreased nutrient transport and fetal growth restriction. Taken together, these data strongly implicate AR-mediated testosterone action as an important pathway contributing to clinical manifestation of preeclampsia. This review critically addresses this hypothesis, taking into consideration both clinical and preclinical data.

1 March 2016 in Hypertension
Verified
Journal Article
Closed access
PDF file
KGKathirvel Gopalakrishnan
Kathirvel Gopalakrishnan
JMJAY MISHRA
JAY MISHRA
VCVijayakumar Chinnathambi
Vijayakumar Chinnathambi
SBSoumya Rahima Benhabbour
Soumya Rahima Benhabbour
IPIgor Patrikeev
Igor Patrikeev
KSKunju Sathishkumar
Kunju Sathishkumar
Elevated maternal testosterone levels are shown to cause fetal growth restriction, eventually culminating in sex-specific adult-onset hypertension that is more pronounced in males than in females. In this study, we tested whether uteroplacental and fetoplacental disturbances underlie fetal growth restriction and if these changes vary in male and female placentas. Pregnant Sprague-Dawley rats were injected with vehicle (n=16) or testosterone propionate (0.5 mg/kg per day from gestation day 15–19; n=16). On gestation day 20, we quantified uterine artery blood flow using microultrasound, visualized placental arterial network using x-ray microcomputed tomography, determined fetoplacental hypoxia using pimonidazole and hypoxia-inducible factor-1α, and used Affymetrix array to determine changes in placental expression of genes involved in vascular development. Plasma testosterone levels increased 2-fold in testosterone-injected rats. Placental and fetal weights were lower in rats with elevated testosterone. Uterine artery blood flow was lower, and resistance index was higher in the testosterone group. Radial and spiral artery diameter and length, the number of fetoplacental arterial branches, and umbilical artery diameter were reduced in the testosterone group. In addition, markers of hypoxia in the placentas and fetuses were elevated in the testosterone group. The magnitude of changes in placental vasculature and hypoxia was greater in males than in females and was associated with sex-specific alteration of unique sets of genes involved in angiogenesis and blood vessel morphogenesis. The results demonstrate that elevated testosterone during gestation induces a decrease in uterine arterial blood flow and fetal sex–related uteroplacental vascular changes, which may set the stage for subsequent sex differences in adult-onset diseases.

13 July 2009 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
BBBiju Bhargavan
Biju Bhargavan
AGAbnish Kumar Gautam
Abnish Kumar Gautam
DSDivya Singh
Divya Singh
AKAmit Kumar
Amit Kumar
SCSumit Chaurasia
Sumit Chaurasia
NCNaibedya Chattopadhyay
Naibedya Chattopadhyay

1 April 2011 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
AGAbnish K. Gautam
Abnish K. Gautam
BBBiju Bhargavan
Biju Bhargavan
ATAbdul M. Tyagi
Abdul M. Tyagi
KSKamini Srivastava
Kamini Srivastava
DYDinesh K. Yadav
Dinesh K. Yadav
DSDivya Singh
Divya Singh

1 January 2012 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BBBiju Bhargavan
Biju Bhargavan
DSDivya Singh
Divya Singh
AGAbnish K. Gautam
Abnish K. Gautam
JMJAY MISHRA
JAY MISHRA
AKAmit Kumar
Amit Kumar
SSSabyasachi Sanyal
Sabyasachi Sanyal